Palantir Technologies Inc. (PLTR) saw its shares tumble to a new 52-week low on Wednesday, reaching $112.94 during intraday trading. The stock closed near that level at $113.19, down $3.51 or roughly 3% from the previous day's close of $116.70. Trading volume was elevated at approximately 26.5 million shares, reflecting heightened investor activity.
The decline came despite a bullish announcement on Tuesday that Palantir and Zeta Global (ZETA) are partnering to create a marketing-focused artificial intelligence platform. Under the agreement, Zeta's Data Cloud will be rebuilt using Palantir Foundry, the company's enterprise data management system, with Zeta's Athena AI layer providing marketing decision-making capabilities. Palantir CEO Alex Karp described the deal as a move that would 'transform this industry,' while Zeta CEO David A. Steinberg emphasized the push for AI-powered marketing on a trusted platform. Zeta indicated the partnership could generate over $100 million in annual revenue for Zeta over the next several years.
Palantir's fundamentals remain strong. The company reported first-quarter total revenue of $1.63 billion, an 85% year-over-year increase. U.S. revenue surged 104% to $1.28 billion, with U.S. commercial revenue jumping 133% to $595 million. Palantir raised its 2026 revenue guidance to a range of $7.65 billion to $7.66 billion, and CEO Karp called it the company's 'highest-ever year-over-year growth rate.'
However, the broader market context weighed heavily on Palantir and other high-valuation tech stocks. The Nasdaq, Dow Jones Industrial Average, and S&P 500 all traded higher on Wednesday after two losing sessions, but technology shares remained under pressure. Brian Mulberry, chief market strategist at Zacks Investment Management, noted a 'really clear rotation' out of recent winners into overlooked names, as reported by Reuters.
Investor concerns center on several fronts. Fears of intensifying competition from AI model companies such as OpenAI and Anthropic have cast a shadow over traditional software firms. Additionally, the prospect of rising interest rates has made high-growth, high-valuation stocks less attractive. Political risks also cloud Palantir's outlook in Europe: France's DGSI intelligence agency plans to replace Palantir with local rival ChapsVision over the next few years, though Palantir maintains its contract is 'fully in force.' Germany's military is reportedly seeking to end its use of Palantir, and the UK is reviewing its contract with the National Health Service (NHS).
Analyst sentiment remains divided. According to MarketScreener, the mean rating among 32 analysts is 'outperform,' with an average price target of $182.75. Targets range from $70 to $255. Recent calls have been mixed: Wolfe Research downgraded the stock to Hold on June 16, while Rosenblatt and Wedbush maintained Buy ratings earlier this month.
Despite the headwinds, Palantir's U.S. commercial business continues to show robust momentum, and the Zeta deal underscores its push into AI-driven marketing. The stock's slide to a 52-week low may present an entry point for some investors, but the combination of valuation concerns, competitive pressures, and geopolitical risks suggests near-term volatility is likely to persist.
